Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Menolytin
- Development stage
- Unknown
- Lead developer
- Grand Medical Group
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Menolytin is a non-hormonal phytocomplex developed by Grand Medical Group as a dietary supplement to support women experiencing symptoms associated with hormonal fluctuations during menstruation, perimenopause, and menopause. Formulated as oral capsules, Menolytin contains a combination of standardized herbal extracts, including *Cimicifuga racemosa* (black cohosh), *Hypericum perforatum* (St. John's wort), *Dioscorea opposita* (wild yam), and *Linum usitatissimum* (flaxseed). These active ingredients work synergistically to provide selective estrogen receptor modulation, serotonergic activity, and anti-inflammatory effects. This helps to alleviate vasomotor symptoms (such as hot flashes and night sweats), improve psychoemotional well-being (reducing anxiety, irritability, and mood swings), and support bone health to reduce the risk of osteoporosis.
- Brand names
- MenolitinMenolytin
02
Targets
ER (Estrogen receptor)SERT (Sodium-dependent serotonin transporter)
Beyond the preview
Go deeper on Menolytin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Menolytin.